Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

Neonatal Opioid Withdrawal Syndrome

7 clinical trials

5 products

Product
CHF6563
Clinical trial
A Phase II, Multicenter, Double Blind, Double Dummy, Randomized, 2 Arms Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome
Status: Terminated, Estimated PCD: 2021-12-13
Product
Morphine
Clinical trial
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations: Conceptual Model Assessments (CMA) Sub-study
Status: Active (not recruiting), Estimated PCD: 2025-01-31
Product
Buprenorphine
Clinical trial
Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations
Status: Active (not recruiting), Estimated PCD: 2025-01-31
Clinical trial
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): Infant Neurodevelopmental Outcomes (INO) Sub-study
Status: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Status: Active (not recruiting), Estimated PCD: 2024-01-31
Product
Methadone
Clinical trial
Understanding the microRNA Response to Opioid Withdrawal and Their Uses as Potential Biomarkers for Neonatal Abstinence Syndrome
Status: Recruiting, Estimated PCD: 2024-10-10
Product
Buccal swab saliva
Clinical trial
Prospective Randomized Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Status: Withdrawn, Estimated PCD: 2021-05-17